KALV (STOCKS)
KalVista Pharmaceuticals, Inc. Common Stock
$19.700000
+0.310000 (+1.60%)
Prev close: $19.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Benjamin L. Palleiko
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,001.91M
- Employees
- 270
- P/E (TTM)
- -4.90
- P/B (TTM)
- -367.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.92 | $-0.48 | +1.3962 | +291.25% |
|
Mar 2025 (Q3)
|
$-0.78 | $-0.89 | +0.1115 | +12.51% |
|
Dec 2024 (Q2)
|
$-0.91 | $-0.93 | +0.0162 | +1.75% |
|
Sep 2024 (Q1)
|
$-0.87 | $-0.93 | +0.0623 | +6.68% |